Gerresheimer completes Centor sale and Gerresheimer stock gains 1.20 percent
Published on 10/07/2026 at 14:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Gerresheimer stock was trading at EUR 28.67 at Lang & Schwarz on October 7, 2026 at 2:29 p.m. CEST, up 1.20 percent from the prior close of EUR 28.33. The company completed the sale of its U.S. subsidiary Centor on October 1, 2026, according to Deutsche Boerse.
Centor proceeds target debt reduction
The completed transaction is part of Gerresheimer's portfolio restructuring. The company said the proceeds will be used to reduce debt, while the sale of its Primary Packaging Plastics business is expected in the first half of 2027.
The latest transaction follows definitive agreements signed in July 2026. Deutsche Boerse reported that the remaining Primary Packaging Plastics closing is expected in the first half of 2027. That timetable keeps debt reduction and refinancing central to the investment case.
Second-quarter recovery remains incomplete
In preliminary second-quarter 2026 results dated September 30, 2026, revenue reached EUR 578.00 million, compared with EUR 614.00 million in the second quarter of 2025, a decline of 5.86 percent. EQS News reported that adjusted EBITDA rose to EUR 102.00 million from EUR 67.00 million in the first quarter of 2026.
The sequential improvement was paired with a year-over-year decline in profitability. Adjusted EBITDA was EUR 20.00 million below the second-quarter 2025 level of EUR 122.00 million, while the adjusted EBITDA margin reached 17.60 percent in the second quarter of 2026.
Investing.com reported that management retained full-year 2026 guidance for organic revenue in the lower half of the EUR 2.30 billion to EUR 2.40 billion range, adjusted EBITDA margin of 17.00 percent to 18.00 percent and free cash flow before mergers and acquisitions of negative EUR 50.00 million to negative EUR 100.00 million.
Stock remains below its yearly high
Gerresheimer had a market capitalization of EUR 991.30 million and a 52-week range of EUR 14.83 to EUR 37.68 as of October 7, 2026. The Lang & Schwarz price therefore stood EUR 9.01 below the 52-week high, equivalent to 23.92 percent below that level.
For investors, the key tension is visible in the numbers: quarterly profitability improved by EUR 35.00 million from the first quarter, but revenue and adjusted EBITDA remained below the prior-year quarter. The asset sales offer a defined route toward lower debt, while operational execution must close the remaining earnings gap.
Debt reduction shapes the next phase
Gerresheimer was trading at EUR 28.67 at Lang & Schwarz on October 7, 2026 at 2:29 p.m. CEST, plus 1.20 percent versus the prior close of EUR 28.33. The latest price sits 23.92 percent below the 52-week high of EUR 37.68, keeping the restructuring milestones relevant to the stock's valuation.
The further course of trading is shown by the continuously updated real-time quote of Gerresheimer stock.
Gerresheimer stock facts
- Company: Gerresheimer AG
- ISIN: DE000A0LD6E6
- WKN: A0LD6E
- Ticker: GXI
- Primary exchange: Frankfurt Stock Exchange
- Price Lang & Schwarz as of October 7, 2026, 2:29 p.m. CEST: EUR 28.67
- Change versus prior close: plus 1.20 percent
- Prior close Lang & Schwarz October 6, 2026: EUR 28.33
- Market capitalization: EUR 991.3 million as of October 7, 2026
- 52-week range: EUR 14.83-EUR 37.68 as of October 7, 2026
- Sector / Industry: Health Care
